KIF20A and neoplasm: To explore the effect of KIF20A on the immune response, we examined immunogenicity, immune checkpoints, immunophenoscore (IPS) (27), and tumor immune dysfunction and exclusion (TIDE) (28) scores, Aneuploidy score, cancer testis antigens (CTA) score, homologous recombination deficiency (HRD), and intratumor heterogeneity, all stratified by KIF20A expression.